Abstract. Endogenously formed catecholoestrogens or their monomethyl ethers were neutralized in the circulation using antisera with high affinity and specificity for 2-hydroxyoestrone and 2-hydroxyoestradiol or 4-hydroxyoestrone and 4-hydroxyoestradiol or the respective methyl ethers in PMS treated immature female rats. The experimental arrangement used was valid as 1) animals treated with PMS and antiserum to oestrone and oestradiol failed to ovulate without impairment of body weight, 2) ovulations could be restored by injections of hCG at the time when rats treated with PMS alone had their ovulatory LH surge and 3) normal rabbit serum had no effect on ovulations and on body weight.
Treatment of the animals with antisera to catecholoestrogens or their methyl ethers had no negative effect on ovulation frequency, number and shape of ova and body weight, although the doses of antisera used \ p=m-\ as calculated from the number of antibody binding sites and affinity constants \p=m-\must (Ferin et al. 1969a ).
For our purposes we chose the model of the immature female rat, which when treated with PMS reacts with follicle maturation, follicular androgen-and oestradiol-production triggering an LH surge followed by ovulations. As (Ferin et al. 1969a ). If circulating catecholoestrogens or their methyl ethers were of importance for the regulation of gonadotrophin release ovulations should be bloc¬ ked by the application of antisera specifically neu¬ tralizing these oestrogens.
Materials and Methods

Antisera and hormones
Oestrone (Ei), 2-hydroxyoestrone (2-OH-Ei), 4-hydroxyoestrone (4-OH-Ej), 2-hydroxyoestrone 2-methyl ether (2-OH-Et 2-Me), and 4-hydroxyoestrone 4-methyI ether (4-OH-Ei 4-Me) were converted to their 17-(0-carboxy)-methyl oximes and coupled to bovine serum albumine (BSA). Antisera to these immunogens were raised in rabbits and characterized as described previously (Ball et al. 1978 saline. Anti-oestrone-17-BSA-serum (Anti-E) was in¬ jected on day 0 and 1 at the same time (0.5 ml each).
Normal rabbit serum, anti-2-OH-Ei-17-BSA-serum (anti-2-OH-E), anti-4-OH-Et-l 7-BSA-serum (anti-4-OH-E), anti-2-OH-Ej 2-Me-17-BSA-serum (anti-2-OH-E 2-Me) and anti-4-OH-E!, 4-Me-l7-BSA-serum (anti-4-OH-E 4-Me) were injected on day 0 and 1 at 14.00 h and on day 2 at 8.00 h (0.5 or 1 ml each). hCG (25 IU) was injected on day 2 at 18.00 h. 4-OH-E2B2 was injected on day 0 at 14.00 h (10 or 20 (ig), on day 1 at 9.00 h (20 or 40 ¡ig) and on day 2 at 9.00 h (40 or 80 ug).
All animals were sacrificed by ether inhalation on day 3 at 9.00 h (28 days old), weighed, the oviducts removed, the ova expelled and counted under a dissecting micro¬ scope.
Results Table 1 gives the cross-reactivities, affinity con¬ stants, and number of antibody binding sites of the antisera pooles used.
Using 20 IU of PMS and the time schedule described above, ova were found in 80-100% of the animals on day 3 at 9.00 h. Saline treated control animals (n = 30) did not ovulate before day 5. Anti-E in the dose used clearly blocked ovula¬ tions without having any significant effect on body weight (Table 2) .
Normal rabbit serum administered in 3 doses of 1 ml each (Methods) showed no effect on ovulation frequency, number and shape of ova, nor on body weight, indicating that non-specific 'toxic' effects of rabbit serum did neither occur systemically nor locally at the ovaries ( (Table 2) .
The injection of different doses of anti-2-OH-E, or anti-4-OH-E, or anti-2-OH-E 2-Me or anti-4-OH-E 4-Me showed no effects on ovulations and number and shape of ova nor on body weight, even when high doses (3x1 ml, Methods) were applied (Table 3) . 
Characteristics of the antisera used for the in vitro neutralization of^and E2 (anti-E), 4-OH-Ei/4-OH-E2 (anti-4-OH-E), 2-OH-E!/2-OH-E2 (anti-2-OH-E), 4-OH-Et 4-Me/4-OH-E2 4-Me (anti-4-OH-E 4-Me) and 2-OH-Ej 2-Me/2-OH-E2 2-Me (anti-2-OH-E 2-Me).
Anti-E Anti-4-OH-E Anti-2-OH-E Anti-4-OH-E (Table 4) .
Discussion
Due to the high cross-reactivities with the 17-hydroxy forms of their respective haptens the antisera raised against oestrone-17-BSA, 2-hy¬ droxyoestrone-17-BSA, 4-hydroxyoestrone-17-BSA, 2-hydroxyoestrone 2-methyl ether-17-BSA and 4-hydroxyoestrone 4-methyl ether-17-BSA Table 3 .
Influence of treatments with either anti-4-OH-E, anti-2-OH-E, anti-4-OH-E 
